Novozymes A/S (OTCMKTS:NVZMY) Reaches New 12-Month High at $66.83

Novozymes A/S (OTCMKTS:NVZMY)’s stock price hit a new 52-week high during trading on Thursday . The stock traded as high as $66.83 and last traded at $66.40, with a volume of 4625 shares changing hands. The stock had previously closed at $65.94.

Novozymes A/S Price Performance

The stock has a market capitalization of $31.10 billion, a PE ratio of 41.73, a price-to-earnings-growth ratio of 3.55 and a beta of 0.89. The business’s 50-day moving average price is $62.29 and its 200 day moving average price is $59.36. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.80 and a current ratio of 1.30.

Novozymes A/S Company Profile

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.